Search research articles
Contact Us
Filters
Showing results (421-430 of 454) with videos related to
Page
of 46
Sort By:
Annals of Surgical Oncology
|
October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy
N Q Mirza, G Vlastos, F Meric, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2007
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy
Sean E McGuire, Ana M Gonzalez-Angulo, Eugene H Huang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 28, 2021
Effector memory cytotoxic CD3<sup>+</sup>/CD8<sup>+</sup>/CD45RO<sup>+</sup> T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer
Xiangjie Sun, Jie Zhai, Baohua Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2005
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
Marjorie C Green, Aman U Buzdar, Terry Smith, et al.
Human Pathology
|
April 12, 2022
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma
Esther C Yoon, Gang Wang, Bryce Parkinson, et al.
Journal of the National Cancer Institute
|
February 18, 2015
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer
Ana M Gonzalez-Angulo, Ian Krop, Argun Akcakanat, et al.
Cancer
|
January 11, 2005
Breast conservation after neoadjuvant chemotherapy
Allen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Nature
|
October 20, 2015
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Lin Zhang, Siyuan Zhang, Jun Yao, et al.
Breast Cancer Research and Treatment
|
June 16, 2021
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
Takeo Fujii, Hiroko Masuda, Yee Chung Cheng, et al.
Oncotarget
|
November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patients
Reva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.
Page
of 46
Search research articles
Search
Showing results (421-430 of 454) with videos related to
Sort By:
Page
of 46
Annals of Surgical Oncology
|
October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy
N Q Mirza, G Vlastos, F Meric, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2007
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy
Sean E McGuire, Ana M Gonzalez-Angulo, Eugene H Huang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 28, 2021
Effector memory cytotoxic CD3<sup>+</sup>/CD8<sup>+</sup>/CD45RO<sup>+</sup> T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer
Xiangjie Sun, Jie Zhai, Baohua Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2005
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
Marjorie C Green, Aman U Buzdar, Terry Smith, et al.
Human Pathology
|
April 12, 2022
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma
Esther C Yoon, Gang Wang, Bryce Parkinson, et al.
Journal of the National Cancer Institute
|
February 18, 2015
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer
Ana M Gonzalez-Angulo, Ian Krop, Argun Akcakanat, et al.
Cancer
|
January 11, 2005
Breast conservation after neoadjuvant chemotherapy
Allen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Nature
|
October 20, 2015
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Lin Zhang, Siyuan Zhang, Jun Yao, et al.
Breast Cancer Research and Treatment
|
June 16, 2021
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
Takeo Fujii, Hiroko Masuda, Yee Chung Cheng, et al.
Oncotarget
|
November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patients
Reva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.
Page
of 46